4th Quarter - Report

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Period 4th Quarter 2008 Filed Jan 20, 2009 Signed by John (Jay) Bonitt, Executive Director, Federal Government Affairs

Official filing
Firm
ELI LILLY AND COMPANY
Client
ELI LILLY AND COMPANY
Income
—
Expenses
$3,390,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare, Medicaid

LobbyistCovered position, as disclosed
JAY BONITT —
JESSIE BRAIRTON —
JESSE PRICE —
SONYA SOTAK ELLING —

Contacted: Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)

Animals ANI

Veterinary medicine (access)

LobbyistCovered position, as disclosed
JESSE SEVCIK New —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE

Trade (domestic/foreign) TRD

EU Duties; Market Access (China, Germany, Czech Republic, Italy, Norway, Poland, United Kingdom, Indonesia); Intellectual Property (Finland, Norway, China, Philippines); Pricing Reform (Czech Republic, Japan, Korea, Thailand)

LobbyistCovered position, as disclosed
KERN BRIGGS —
HARRISON C COOK —
DESIREE FILIPPONE —
JESSE SEVCIK New —
DAVID TALBOT —

Contacted: Office of Management & Budget (OMB); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); State, Dept of (DOS); Agriculture, Dept of (USDA); Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

Patent Reform (HR 1908, S 1145); Follow-on Biologics (HR 5629, HR 1956, HR 1038, S 623, S 1695); Intellectual Property (Finland, Norway)

LobbyistCovered position, as disclosed
BRUCE ARTIM —
KERN BRIGGS —
DAVID TALBOT —

Contacted: SENATE; State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Bills named: H.R. 1038 (110th), H.R. 5629 (110th), H.R. 1956 (110th), H.R. 1908 (110th)

Health Issues HCR

Comparative Effectiveness (S 3408); Food & Drug Safety (HR 3610); Biosimilars (HR 5629, HR 1956, HR 1038, S 1695); Transparency (S 2029, HR 5605); Healthcare Reform (Belgium, Germany, Italy, United Kingdom, South Africa); MDR-TB

LobbyistCovered position, as disclosed
BRUCE ARTIM —
JAY BONITT —
JESSIE BRAIRTON —
SEAN DONOHUE —
DESIREE FILIPPONE —
SONYA SOTAK ELLING —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); SENATE; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); State, Dept of (DOS); Commerce, Dept of (DOC)

Bills named: H.R. 3610 (110th), H.R. 1956 (110th), H.R. 1038 (110th), H.R. 5629 (110th), H.R. 5605 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.